{"id":"NCT00675948","sponsor":"Jazz Pharmaceuticals","briefTitle":"Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain","officialTitle":"An Open-label, Extension Study, to Investigate the Long-term Safety and Tolerability of Cannabis Based Medicine Extracts in Patients With Cancer-related Pain.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2002-04","primaryCompletion":"2006-09","completion":"2006-09","firstPosted":"2008-05-12","resultsPosted":"2012-09-13","lastUpdate":"2023-05-03"},"enrollment":43,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Pain","Cancer"],"interventions":[{"type":"DRUG","name":"Sativex","otherNames":["GW-1000-02"]},{"type":"DRUG","name":"GW-2000-02","otherNames":[]}],"arms":[{"label":"Sativex","type":"EXPERIMENTAL"},{"label":"GW-2000-02","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess the safety and tolerability of long term therapy with Sativex® and GW-2000-02.","primaryOutcome":{"measure":"The Incidence of Adverse Events as a Measure of Subject Safety","timeFrame":"0 - 657 days","effectByArm":[{"arm":"Sativex","deltaMin":37,"sd":null},{"arm":"THC Alone","deltaMin":4,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":13},"locations":{"siteCount":1,"countries":["United Kingdom"]},"refs":{"pmids":["23141881"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":20,"n":39},"commonTop":["Malignant neoplasm progression","Vomiting","Nausea","Dizziness","Somnolence"]}}